Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jul-Sep;14(3):386-90.
doi: 10.4293/108680810X12924466007403.

Uterine artery occlusion for treatment of symptomatic uterine myomas

Adel Helal  1 , Abd El-Mageed Mashaly, Talal Amer
Affiliations
Randomized Controlled Trial

Uterine artery occlusion for treatment of symptomatic uterine myomas

Adel Helal et al. JSLS. 2010 Jul-Sep.

Abstract

Objective: To compare the effectiveness and safety of uterine artery occlusion by laparoscopy versus embolization as a treatment modality for symptomatic uterine fibroids.

Methods: Ninety-six premenopausal women with symptomatic uterine leiomyomata were studied. None of them desired further pregnancy. They were randomized to treatment either by laparoscopic occlusion (group 1) or by radiologic embolization of uterine arteries (group 2). The primary outcome measure was patient satisfaction as regards menstrual blood loss compared with pretreatment loss. Secondary outcome measures included postoperative pain, complications, secondary interventions, and failures.

Results: Ninety women were followed for 1, 3, 6, and 12 months after both procedures. The primary outcome was comparable between the 2 groups (86.7% after laparoscopic occlusion versus 88.8% after embolization, with no statistically significant difference). After 12 months of follow-up, more patients resumed heavy periods in the uterine artery occlusion group [4/45 patients, 8.8% in occlusion group compared with 3/45 (6.6%) in embolization group, P=0.044].

Conclusion: Both laparoscopic occlusion and superselective embolization of uterine arteries improved clinical symptoms in the majority of patients. At 12-month follow-up, embolization might be more effective.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Pain and nausea recorded in the first 48 hours after treatment. SEM=standard error of the mean.
See this image and copyright information in PMC

References

    1. Vollenhoven BJ, Lawrence AS, Healy D. Uterine fibroids: a clinical review. Br J Obstet Gynecol. 1990;97:285–298 - PubMed
    1. Worthington-Kirsch RL, Popky GL, Hutchins FL. Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response. Radiology. 1998;208:225–229 - PubMed
    1. Goodwin SC, McLucas B, Lee M, et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol. 1999;10:1159–1165 - PubMed
    1. Healy D, Vollenhoven BJ. The role of GnRH agonists in the treatment of uterine fibroids. Br J Obstet Gynecol. 1992;99:23–26 - PubMed
    1. Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000;215:228–231 - PubMed

Publication types

LinkOut - more resources